Cytogenetic studies have demonstrated the importance of aneuploidy in differentiated thyroid cancer development. The pituitary tumour transforming gene (PTTG), also known as securin, is a mitotic checkpoint protein which inhibits sister chromatid separation during mitosis. PTTG is highly expressed in many cancers and overexpression of PTTG induces aneuploidy in vitro. Using fluorescent intersimple sequence repeat PCR (FISSR-PCR), we investigated the relationship between PTTG expression and the degree of genetic instability in normal and tumorous thyroid samples. The genomic instability index (GI index) was 6.7-72.7% higher in cancers than normal thyroid tissues. Follicular thyroid tumours exhibited greater genetic instability than papillary tumours (27.6% (n ¼ 9) versus 14.5% (n ¼ 10), P ¼ 0.03). We also demonstrated a strong relationship between PTTG expression and the degree of genetic instability in thyroid cancers (R 2 ¼ 0.80, P ¼ 0.007). To further investigate PTTG's role in genetic instability, we transfected FTC133 thyroid follicular cells and observed increased genetic instability in cells overexpressing PTTG compared with vector-only-transfected controls (n ¼ 3, GI Index VO ¼ 29.775.2 versus PTTG ¼ 63.776.4, P ¼ 0.013). Further, we observed a dose response in genetic instability and PTTG expression (GI Index low dose (0.5 lg DNA/ six-well plate) PTTG ¼ 15.3%71.7 versus high dose (3 lg DNA) PTTG ¼ 50.8%73.3, P ¼ 0.006). Overall, we describe the first use of FISSR-PCR in human cancers, and demonstrate that PTTG expression correlates with genetic instability in vivo, and induces genetic instability in vitro. We conclude that PTTG may be an important gene in the mutator phenotype development in thyroid cancer.
Oncogene ( Keywords: PTTG; thyroid cancer; ISSR-PCR; genetic instability Measurement of genetic instability, a hallmark feature of solid tumours that is implicated in both initiation and progression of cancers, may serve as a valuable molecular marker of prognosis. Thyroid cancer, the most common endocrine cancer, has been shown to display aneuploidy, one form of genetic instability (Taruscio et al., 1994) . Earlier cytogenetic studies measuring loss of heterozygosity (LOH) in thyroid tumours demonstrated greater overall prevalence of LOH in malignant lesions than in benign pathologies (Barril et al., 2000; Dobosz et al., 2000) with greatest LOH rates evident in the more aggressive cancers. The majority of earlier studies have investigated gross chromosomal changes, due primarily to absence of reliable techniques to measure smaller intrachromosomal mutations. However, a relatively new technique termed intersimple sequence repeat PCR (ISSR-PCR) has been shown to provide a simple and reliable measure of intrachromosomal instability. Basik et al. (1997) first used ISSR-PCR to quantitate genetic instability in sporadic colorectal cancers. Their technique was adapted from the original method described by Zietkiewicz et al. (1994) who used primers anchored to simple repeat sequences as a rapid genetic fingerprinting technique for plant phylogenetic studies. The application of techniques such as ISSR-PCR, which allow measurement of smaller genomic alterations, has revealed that mutation rates in human cancer are significantly higher than had been previously estimated (Loeb, 1991) .
Pituitary tumour transforming gene (PTTG) is a proto-oncogene, first identified from rat pituitary GH4 cells in 1997 (Pei and Melmed, 1997) . Increased expression of PTTG has been shown in many cancer cell lines and human tumours (including colorectal, breast, haematopoietic, and pituitary tumours) compared with normal tissues (Zhang et al., 1999; Heaney et al., 2000; Saez et al., 2002; Solbach et al., 2004) . We recently reported significantly higher expression of PTTG in thyroid cancers compared with normal thyroid. In addition, we reported that high PTTG expression in thyroid cancers was an independent predictor of early tumour recurrence (Boelaert et al., 2003a) . Others have shown high PTTG expression in breast and colorectal cancers to predict recurrence, as well as nodal and distant metastases Solbach et al., 2004) . Furthermore, a large microarray analysis of solid tumours indicated PTTG to be a member of a 17-gene signature that predicts future metastasis from primary cancers (Ramaswamy et al., 2001) .
PTTG, also known as human securin, is a mitotic checkpoint gene involved at the metaphase-anaphase interface. First evidence suggesting a role in the development of genetic instability came from an in vitro study which demonstrated PTTG to induce aneuploidy, arising from chromatid mis-segregation. (Yu et al., 2003) Subsequently, several studies have suggested that PTTG may also play an important role in generating intrachromosomal instability. PTTG has also been shown to interact directly with Ku70 heterodimer, which is involved in the protein kinase-dependent DNA (PK-DNA) double-strand break (DSB) repair pathway (Romero et al., 2001) . DNA DSBs resulted in reduction of PTTG-Ku70 complexes, releasing free Ku70 to trigger the PK-DNA repair pathway. More recently, PTTG interaction with separase, and its stabilization, was shown to be a potentially novel and important DNA DSB repair mechanism, acting through the cleavage of cohesin (Nagao et al., 2004) . It was subsequently proposed that the PTTG-separase complex might aid DNA repair by removing local cohesion molecules in interphase cells to allow DNA repair machinery access to damaged DNA sequences.
PTTG has also been shown to be involved in normal UV and chemotoxic DNA damage response pathways in mammalian cells (Zhou et al., 2003; Romero et al., 2004) . PTTG is downregulated in response to DNA damage, and it is postulated that this repression of PTTG expression is important in triggering downstream DNA repair mechanisms. Aberrant expression of PTTG, found in many cancers, may interfere with, and suppress, any such PTTG-dependent DNA damage response pathways, resulting in rapid accumulation of mutations. These and other similar observations suggest, therefore, that PTTG may play an important role in the development of intrachromosomal genetic instability.
Based on these in vitro investigations in human and yeast cells, we hypothesized that, in addition to aneuploidy, cancers overexpressing PTTG might show increased accumulation of global genetic instability, resulting from interferences in DNA damage pathways. We therefore characterized genetic instability in a cohort of thyroid cancers using a fluorescent intersimple sequence repeat PCR assay (FISSR-PCR). This study represents the first to evaluate genetic instability in a human cancer using FISSR-PCR. We also investigated whether PTTG might play a role in generating genetic instability by correlating PTTG expression with the degree of genetic instability detected in the tumours and by performing in vitro studies using human thyroid follicular cells to examine whether PTTG expression had a direct role in the development of genetic instability in human thyroid cells.
We have modified the conventional method of ISSR-PCR by using fluorescent FAM-labelled primers and a Genescan/ABI 377 platform to improve assay sensitivity and objectivity. Other reports using a similar method of FISSR-PCR in plant taxonomy have demonstrated around a three-fold increase in product detection and more objective PCR-product sizing and quantitation (Kumar et al., 2001; Nagaraju et al., 2002) . In these studies, FISSR-PCR was able to detect low-signal products more accurately than a conventional isotopic ISSR technique and allowed correct differentiation between closely related plant species that were otherwise missed with conventional ISSR-PCR (Kumar et al., 2001) . Using the same (CA)8RG primer used by Basik et al and others (Viswanathan et al., 2003) , FAMlabelling permitted the detection of a far greater number of PCR products from thyroid specimens in the present study. We were also able to discriminate on an average a three-fold increase in the number of PCR products within a comparable product size range.
Using FISSR-PCR, we demonstrated that the level of genetic instability is highly variable in thyroid cancers and that the overall extent of genetic instability is far greater than has been previously reported by others using an ISSR-PCR assay (Stoler et al., 2002; Wiseman et al., 2003) . Using FISSR-PCR, the genetic instability (GI index values) ranged from 17.5 to 72.7% (mean 35.3%) in a group of seven fresh cryopreserved thyroid cancer specimens and from 2.8 to 52.4% (mean 20.7%) in 19 formalin-fixed paraffin-embedded (FFPE) thyroid cancer specimens (Figure 1a) . The significant improvement in product detection sensitivity may account for the greater number of mutations observed in cancers compared with normal tissues in this present study. Many alterations in the low-signal products that may be missed using the conventional ISSR technique would have been detected and included in calculating the GI index values. Indeed, we show that a minority of tumours exhibit potentially catastrophic levels of genetic instability raising the issue of how such tumours survive and progress. As the greater portion of the human genome is noncoding, mutations in these regions would not be deleterious. Genetic instability is a dynamic process and mutations that arise as a consequence accrue cumulatively with time. Static measures of gene alteration in a given tissue by FISSR-PCR quantifies the total number of genetic alterations accumulated rather than provide an assessment of the rate of mutation at the given time point. Overall, in those tumours exhibiting extremely high genetic instability, many gene mutations detected may be nonlethal, and those that are significant may have been compensated for over a significant evolutionary period of tumour development.
We then determined whether the degree of genetic instability measured in thyroid cancers by FISSR-PCR was related to tumour type (follicular versus papillary). In paraffin-embedded (FFPE) thyroid tumours, we observed a significantly greater average GI index in follicular cancers (27.6%) compared with papillary cancers (14.5%, P ¼ 0.03) (Figure 1b) . Previously, follicular cancers have been shown, using measurement of LOH, to exhibit a greater chromosomal instability than papillary cancers (Ward et al., 1998) . In this study, we have also been able to demonstrate greater intrachromosomal instability in follicular cancers than in papillary cancers using FISSR-PCR. This observation is not unexpected given that follicular cancers are associated with a worse prognosis and show more aggressive biological behaviour (Schlumberger, 1998) . It may be hypothesized that the higher genetic instability in follicular cancers may result in the more aggressive phenotype. Using ISSR-PCR, Wiseman et al. (2003) observed an inverse relationship between age of disease onset and degree of genetic instability in a series of papillary thyroid cancers. The extent of genetic instability may thus determine the age of presentation of thyroid cancers.
To investigate whether PTTG may play a role in the genetic instability observed in thyroid cancer, we examined the relationship between PTTG mRNA expression and GI index values in individual tumours. We showed that PTTG mRNA expression in both snapfrozen thyroid cancers (n ¼ 7, R 2 ¼ 0.80, P ¼ 0.007) and FFPE thyroid cancers (n ¼ 11, R 2 ¼ 0.46, P ¼ 0.021) were significantly associated with the degree of genetic instability (GI index). When the GI index values for the fresh frozen and FFPE thyroid specimens were combined, there was overlap in data points, and the strong positive association between PTTG expression and GI index was enhanced (n ¼ 18, R 2 ¼ 0.66, P ¼ o 0.001) (Figure 2 ).
Having observed a strong positive correlation between PTTG mRNA expression and genetic instability in ex vivo thyroid tissues, we next sought to determine whether PTTG might directly induce genetic instability in vitro. Human follicular thyroid cells (FTC133) harvested 48 h after transfection and shown to express increased PTTG expression at mRNA and protein level (Figure 3a ) exhibited significantly greater genetic instability compared with vector-only-transfected control cells (VO) (n ¼ 9, PTTG-transfected GI index ¼ 63.7%, VO GI index ¼ 29.7%, P ¼ 0.013) (Figure 3b ). We also demonstrated a positive dose response in genetic instability induction in response to more marked PTTG overexpression compared with less marked overexpression (GI Index 'low dose' (LD) PTTG ¼ 15.3%71.7 versus 'high dose' (HD) PTTG ¼ 50.8%73.3, n ¼ 3, P ¼ 0.006) (Figure 3c ). These findings suggest that PTTG is directly involved in inducing genetic instability in FTC133 cells, and does so in a dose-dependent manner.
A previous study has suggested that increased PTTG expression promotes cell apoptosis via a p53-dependent Figure 2 Scatter plot correlating fold change in PTTG mRNA expression and GI index values for the thyroid cancers. Correlation between PTTG mRNA expression and degree of genetic instability in 18 thyroid cancers (RNA extraction and real-time PCR analysis was possible in 11 of the total 19 fixed thyroid specimens) showing strongly positive relationship between degree of genetic instability (GI index) and level of PTTG mRNA expression. Total RNA was also isolated from each sample using a custom Paraffin Block RNA isolation kit (Ambion Inc., Austin, TX, USA). RNA was reverse transcribed using avian myeloblastosis virus reverse transcriptase (Promega Corp., Madison, WI, USA) in a total reaction volume of 20 ml, with 1 mg thyroid total RNA and 30 pmol random hexamer primers. Expression of specific mRNAs was determined using the ABI PRISM 7700 Sequence Detection System, as described previously ( FISSR-PCR amplifications were carried out using a 5 0 -FAMlabelled primer (CA) 8 RG in 50 ml reactions containing 5ng of sample genomic DNA, 1X PCR reaction buffer, 1.5 mM MgCl 2 , 1.5 mM primer and 0.2 mM mix of dNTPs, with 0.75 Un of TaqDNA polymerase (Fermentas, Hanover, MD, USA). The thermal cycling conditions were as follows: initial denaturation of 5 min at 951C, 35 cycles of 30 s at 941C, 30 s at 501C and 1 min at 721C, final extension of 10 min at 721C. PCR product was (1 ml) mixed with 1.5 ml of 5X loading buffer, and 0.25 ml of GENESCAN-2500 ROX-labelled molecular weight standard (red fluorescence) was included in the loading samples. The samples were denatured at 951C for 5 min before loading onto an ABI 377 automated sequencer (Applied Biosystems) and electrophoresed on 5% polyacrylamide gel (Long Ranger, FMC) under denaturing conditions. Three replicate experiments per sample were carried out to verify the reproducibility of markers. The degree of genetic instability was determined according to Basik et al. (1997) to generate the genetic instability index (GI index), which represents the standard measure of genetic instability with ISSR-PCR analysis pathway (Yu et al., 2000) . It is feasible that false positive results may have resulted from detection of apoptoticdegraded DNA fragments by the sensitive FISSR-PCR method. To investigate this possibility, we determined whether significant apoptosis was induced during the in vitro experiments above. FTC133 cells were transfected with PTTG to induce increased PTTG expression. Caspase 3 and 7 enzyme activity in these cells was compared with both untransfected (negative control) and VO-control-transfected cells (Figure 4) . Untransfected cells exposed to etoposide were used as a positive control for apoptosis induction. Both PTTG-and VOtransfected cells were also exposed to etoposide. We observed no increase in caspase 3/7 activity in PTTG overexpressing cells compared with VO-transfected cells (VO ¼ 1.4770.14 RLU (relative light units)/RLU untransfected cells (RLU control); PTTG ¼ 1.4270.08 RLU/RLU control; P ¼ 0.4), whereas, as expected, untransfected cells exposed to etoposide showed a marked increase in caspase activity (etoposide ¼ 2.6270.35 RLU/RLU control; P ¼ 0.02). PTTG-overexpressing cells did not demonstrate any protective effect against etoposide-driven apoptosis nor synergism with etoposide insult. In addition, FACS analysis using propidium iodide staining (data not included) failed to demonstrate any significant increase in the sub-G1 population. Given these findings, it is likely that the FISSR genetic instability values reported accurately represent gene mutation events rather than apoptotic DNA fragments. In support of this, a more recent study has shown that high PTTG expression suppresses the p53-dependent apoptotic pathway. (Bernal et al., 2002) Thus, we have shown that PTTG does not induce or influence apoptosis in FTC133 cells, but can elicit significant genetic instability.
The precise mechanism involved in the PTTG-driven genetic instability we have demonstrated remains unknown. Increased expression of PTTG, observed in most tumours, may sequester Ku70 heterodimers (Romero et al., 2001) , inhibiting the release of free Ku70 necessary for triggering the protein kinasedependent DNA (PK-DNA) DSB repair pathway. More recently, PTTG interaction with separase was shown to cells were transfected using Fugene-6 reagent (Promega Corp.) with an optimized ratio of 3 ml per mg plasmid DNA. pCI-neo-PTTG, which housed the full-length human PTTG cDNA, was kindly provided by Professor Shlomo Melmed (University of California School of Medicine, Los Angeles, CA, USA). Transfection efficiency was assessed via b-gal staining. Western blot analyses for PTTG expression were performed as described previously (Boelaert et al., 2003b; McCabe et al., 2003) Figure 4 Functional caspases 3 and 7 assays. Luciferase reporterbased caspase assays from FTC133 cells transfected with PTTG and empty plasmid (VO). The effect of increased PTTG expression and etoposide on caspase activity was determined using the Caspase-Glo assay (Promega Corp. Madison, WI, USA) according to the manufacturer's instructions. 2 Â 10 4 cells per well were incubated in white 96-well plates (Corning Corp., USA). As a positive control for apoptosis, the chemotoxic agent, etoposide (1 : 1000), was added to the cell medium 24 h after transfection. Caspase activity was measured 48 h after transfection using an Orion Luminometer (Flowgen, UK). All samples were assayed in triplicate PTTG induces genetic instability D Kim et al be a potentially new and important DNA DSB repair mechanism, acting through cleavage of the cohesin complex. It has been proposed that the PTTG-separase complex might aid DNA repair by removing local cohesion molecules in interphase cells to allow access for local DNA repair machinery to damaged DNA sequences. Alternatively, increased PTTG expression may disrupt the fine regulation of the PTTG-separase complex and thus adversely affect cleavage of rad21, the major target substrate of separase, which is also an important DNA DSB repair gene (Nagao et al., 2004) . PTTG is a target gene of both the UV damage response and chemotoxic damage response pathways in mammalian cells (Zhou et al., 2003; Romero et al., 2004) Resulting DNA-damage results in significant downregulation of PTTG expression, believed to be an essential event for normal cell repair response. Increased expression of PTTG, as seen in numerous cancers, would hence abrogate these DNA damage response pathways. P21(WAF1/CIP1) is a well-known target gene of p53-dependent DNA damage response pathway, and causes cell cycle arrest at G1 phase to allow time for repairs. Although the role of p21 in cancer is unclear, it has been shown that the C-terminal domain of p21 strongly inhibits nucleotide excision repair (Cooper et al., 1999) . Microarray analysis of increased p21 function in p21-9 cells demonstrated inhibition of many DNA repair genes, and cells expressing high p21 secreted proteins with antiapoptotic and promitogenic activities (Chang BD et al., 2000b) . P21 has also been shown to be upregulated by several other genes, including PTTG (Mu et al., 2003) , via non-p53-dependent pathways. (Chang B et al., 2000a) PTTG-dependent upregulation of p21 may represent an important downstream effect in the PTTG-driven genetic instability. Overall, however, PTTG appears to be involved in several genome repair pathways and the disruption of these genome defence mechanisms might result in generation of marked intrachromosomal instability, as we have shown in this study. The precise mechanisms involved in the PTTGdriven genetic instability require elucidation.
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In summary, we have demonstrated that FISSR-PCR is a sensitive method for detecting and measuring genetic instability in human tissues. Using this technique, we have shown the degree of genetic instability to be strongly related to PTTG expression in thyroid tumours.
In vitro experiments supported a direct and causal role for PTTG in generating the genetic instability observed in thyroid cancers. Given these findings, we propose that PTTG may play a critical role in the development of genetic instability observed in thyroid cancer and that this mechanism may be instrumental in both tumour initiation and progression.
